DLF Ltd. saw its share price rise nearly 4% on Thursday after global brokerage firm CLSA upgraded the stock to ‘High Conviction Outperform’ from ‘Outperform’. CLSA has set a target price of Rs 975, ...

CLSA downgraded Toyota (TM) to Hold from Outperform with an unchanged 3,000 yen price target after Toyota reported 3QFY3/25 results on Wednesday and the market reacted “favorably.” Toyota ...

Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold’ with a target of Rs 270, while Morgan Stanley maintains an ‘Overweight’ rating ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ratings to 'outperform.' Dr Reddy's Laboratories falls 1% after a downgrade to ...

Global brokerage firm CLSA has released its 2025 outlook for India's healthcare sector, projecting an 8-9 percent growth in the Indian pharmaceutical market, slightly outpacing the anticipated ...

On Thursday, CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from ...